Adel Wassef

1.4k total citations
35 papers, 1.1k citations indexed

About

Adel Wassef is a scholar working on Psychiatry and Mental health, Social Psychology and Biological Psychiatry. According to data from OpenAlex, Adel Wassef has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 6 papers in Social Psychology and 6 papers in Biological Psychiatry. Recurrent topics in Adel Wassef's work include Schizophrenia research and treatment (13 papers), Epilepsy research and treatment (7 papers) and Tryptophan and brain disorders (6 papers). Adel Wassef is often cited by papers focused on Schizophrenia research and treatment (13 papers), Epilepsy research and treatment (7 papers) and Tryptophan and brain disorders (6 papers). Adel Wassef collaborates with scholars based in United States, Japan and United Arab Emirates. Adel Wassef's co-authors include Jeffrey D. Baker, Lisa D. Kochan, David G. Daniel, Kenneth W. Sommerville, Daniel E. Casey, Patricia Wozniak, Katherine Tracy, Michael W. O’Boyle, A. F. Brown and Robert M. Rose and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neuropsychologia.

In The Last Decade

Adel Wassef

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adel Wassef United States 16 510 188 174 164 147 35 1.1k
Jens M. Langosch Germany 21 676 1.3× 166 0.9× 85 0.5× 123 0.8× 180 1.2× 54 1.1k
Hajime Kazamatsuri Japan 22 515 1.0× 285 1.5× 178 1.0× 79 0.5× 98 0.7× 50 1.2k
S. Tuinier Netherlands 21 493 1.0× 173 0.9× 209 1.2× 305 1.9× 72 0.5× 86 1.3k
R. Weizman Israel 17 327 0.6× 332 1.8× 235 1.4× 253 1.5× 67 0.5× 37 1.1k
Agnieszka Samochowiec Poland 21 321 0.6× 275 1.5× 210 1.2× 288 1.8× 57 0.4× 86 1.2k
Amihai Rigbi Israel 17 223 0.4× 127 0.7× 169 1.0× 181 1.1× 104 0.7× 38 845
V.L. Nimgaonkar United States 18 477 0.9× 291 1.5× 244 1.4× 133 0.8× 48 0.3× 31 1.1k
Antonio Labad Spain 18 251 0.5× 136 0.7× 171 1.0× 275 1.7× 56 0.4× 27 1.1k
Michael A. Reveley United Kingdom 19 439 0.9× 122 0.6× 101 0.6× 177 1.1× 59 0.4× 33 976
Diego Luiz Rovaris Brazil 18 554 1.1× 130 0.7× 158 0.9× 161 1.0× 72 0.5× 72 1.1k

Countries citing papers authored by Adel Wassef

Since Specialization
Citations

This map shows the geographic impact of Adel Wassef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Wassef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Wassef more than expected).

Fields of papers citing papers by Adel Wassef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Wassef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Wassef. The network helps show where Adel Wassef may publish in the future.

Co-authorship network of co-authors of Adel Wassef

This figure shows the co-authorship network connecting the top 25 collaborators of Adel Wassef. A scholar is included among the top collaborators of Adel Wassef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel Wassef. Adel Wassef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Gillian, et al.. (2018). Canine pancreatic lipase immunoreactivity concentrations associated with intervertebral disc disease in 84 dogs. Journal of Small Animal Practice. 59(5). 305–310. 18 indexed citations
2.
Shehab, Abdulla, Bayan Al-Dabbagh, Wael Almahmeed, et al.. (2012). Characteristics and in-hospital outcomes of patients with acute coronary syndromes and heart failure in the United Arab Emirates. BMC Research Notes. 5(1). 534–534. 4 indexed citations
3.
Gandhi, Shilpa K, et al.. (2012). Lengthened temporal integration in schizophrenia. Neuropsychologia. 51(2). 372–376. 17 indexed citations
4.
Hood, Ashley J., et al.. (2011). Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: A saccadic eye movement study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(7). 1753–1764. 15 indexed citations
5.
Pettit, Jeremy W., et al.. (2005). Ratings of Early Major Depressive Disorder Symptom Change During a Brief Psychiatric Hospitalization. Psychiatric Quarterly. 76(1). 33–48. 10 indexed citations
6.
Wassef, Adel, et al.. (2005). Lower Effectiveness of Divalproex Versus Valproic Acid in a Prospective, Quasi-Experimental Clinical Trial Involving 9,260 Psychiatric Admissions. American Journal of Psychiatry. 162(2). 330–339. 14 indexed citations
7.
Casey, Daniel E., David G. Daniel, Adel Wassef, et al.. (2003). Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia. Neuropsychopharmacology. 28(1). 182–192. 165 indexed citations
8.
Gyulai, L., Charles L. Bowden, Susan L. McElroy, et al.. (2003). Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression. Neuropsychopharmacology. 28(7). 1374–1382. 122 indexed citations
9.
Wassef, Adel, Jeffrey D. Baker, & Lisa D. Kochan. (2003). GABA and Schizophrenia: A Review of Basic Science and Clinical Studies. Journal of Clinical Psychopharmacology. 23(6). 601–640. 196 indexed citations
10.
Wassef, Adel, et al.. (2001). Divalproex Sodium Augmentation of Haloperidol in Hospitalized Patients With Schizophrenia: Clinical and Economic Implications. Journal of Clinical Psychopharmacology. 21(1). 21–26. 26 indexed citations
11.
12.
13.
Wassef, Adel, et al.. (2000). Randomized, Placebo-Controlled Pilot Study of Divalproex Sodium in the Treatment of Acute Exacerbations of Chronic Schizophrenia. Journal of Clinical Psychopharmacology. 20(3). 357–361. 77 indexed citations
14.
Wassef, Adel, et al.. (1999). Critical Review of GABA-ergic Drugs in the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. 19(3). 222–232. 53 indexed citations
15.
Wassef, Adel, et al.. (1998). Effectiveness of one-year participation in school-based volunteer-facilitated peer support groups.. PubMed. 33(129). 91–7. 12 indexed citations
16.
Wassef, Adel, et al.. (1996). In search of effective programs to address students' emotional distress and behavioral problems part III: student assessment of school-based support groups.. PubMed. 31(121). 1–16. 9 indexed citations
17.
Wassef, Adel, et al.. (1996). Mental health providers' perceptions of cultural variables in evaluating ethnically diverse clients.. Professional Psychology Research and Practice. 27(3). 284–288. 1 indexed citations
18.
Wassef, Adel, Michael W. O’Boyle, Russell Gardner, et al.. (1992). Glucocorticoid receptor binding in three different cell types in major depressive disorder: Lack of evidence op receptor binding defect. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 16(1). 65–78. 10 indexed citations
19.
Wassef, Adel. (1990). Mononuclear leukocyte glucocorticoid receptor binding characteristics and down-regulation in major depression. Psychoneuroendocrinology. 15(1). 59–68. 21 indexed citations
20.
Harbour, Deborah V., et al.. (1988). Decreased mononuclear leukocyte TSH responsiveness in patients with major depression. Biological Psychiatry. 23(8). 797–806. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens M. Langosch Breakdown of academic impact, for papers by Hajime Kazamatsuri Breakdown of academic impact, for papers by S. Tuinier Breakdown of academic impact, for papers by R. Weizman Breakdown of academic impact, for papers by Agnieszka Samochowiec Breakdown of academic impact, for papers by Amihai Rigbi Breakdown of academic impact, for papers by V.L. Nimgaonkar Breakdown of academic impact, for papers by Antonio Labad Breakdown of academic impact, for papers by Michael A. Reveley Breakdown of academic impact, for papers by Diego Luiz Rovaris
Rankless by CCL
2026